Close Menu

Young Investigator Profile: Jonathan Karr

Model of the System

Fellow, Mount Sinai School of Medicine

Recommended by Eric Schadt, Mount Sinai School of Medicine

NEW YORK (GenomeWeb) – When Jonathan Karr was finishing college, systems biology was taking off and becoming popular. As a senior, he took a systems biology class and was hooked.

"I just really loved the course and the approach to biology — there was a sort of logical, mathematical, and physical way of thinking about biological systems to generate predictions," Karr told GenomeWeb. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.